Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q2)Feb 28, 2026 | (Q1)Nov 30, 2025 | (FY)Aug 31, 2025 | (Q4)Aug 31, 2025 | (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 811.41%469.37K | -50.42%694.11K | 9.49%2.71M | -174.16%-1.24M | 151.18%2.5M | 119.91%51.5K | 1,939.21%1.4M | 241.55%2.47M | 153.96%1.67M | -27.83%993.88K |
| Net income from continuing operations | 1,547.00%3.92M | 38.55%565.09K | -21.28%484.85K | -119.57%-206.11K | 345.27%45.22K | 1,842.16%237.89K | 200.64%407.84K | 167.40%615.91K | 1,041.27%1.05M | 97.25%-18.44K |
| Operating gains losses | ---- | ---- | --101.59K | --43.22K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -64.82%124.56K | -63.31%120.11K | 2.50%1.3M | -16.10%295.43K | 3.68%320.67K | 16.02%354.02K | 9.35%327.38K | 25.02%1.27M | 45.57%352.1K | 0.33%309.28K |
| Remuneration paid in stock | -185.47%-139.45K | -10.50%185.06K | 27.63%656.9K | --157.76K | -45.52%129.23K | -12.79%163.15K | 128.59%206.76K | -46.54%514.71K | --0 | -17.06%237.18K |
| Deferred tax | 39.47%-11.13K | 64.50%-11.13K | -828.51%-267.68K | -583.66%-193.05K | -8.57%-24.88K | 19.73%-18.4K | -36.86%-31.36K | 61.60%-28.83K | 626.36%39.91K | -1.84%-22.91K |
| Other non cashItems | -13.82%166.34K | 9.55%213.63K | -5.18%821.33K | -32.96%248.86K | 15.46%184.45K | 14.04%193.01K | 17.52%195.01K | -31.83%866.17K | 92.91%371.23K | -56.09%159.75K |
| Change In working capital | 157.30%503.23K | -228.61%-378.64K | 49.26%-385.36K | -985.96%-1.58M | 442.03%1.78M | 0.61%-878.19K | 599.63%294.41K | 75.18%-759.46K | 96.06%-145.95K | -67.70%329.02K |
| -Change in receivables | -707.18%-147.32K | -141.61%-488.76K | 25.47%-218.92K | 191.97%272.46K | -17.76%-270.83K | 60.05%-18.25K | -81.64%-202.29K | -61.33%-293.73K | 127.29%93.32K | -7,336.97%-229.99K |
| -Change in inventory | -21.44%242.98K | 28.80%-190.33K | 8.75%-205.12K | 31.65%-442.81K | -71.41%195.73K | 184.70%309.29K | -357.92%-267.32K | 93.48%-224.79K | 71.76%-647.88K | 226.99%684.61K |
| -Change in prepaid assets | 141.06%110.24K | -96.13%5.53K | 84.48%-238.26K | -3,615.60%-1.34M | 507.72%1.23M | 77.77%-268.52K | 1,179.08%143.05K | -55.46%-1.53M | 93.79%-36.16K | 27.69%-301.83K |
| -Change in payables and accrued expense | 133.01%297.32K | -52.51%294.92K | -78.60%276.94K | -116.00%-71.18K | 256.26%627.86K | -222.49%-900.71K | 1,095.42%620.97K | -16.77%1.29M | 191.21%444.77K | -91.06%176.24K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 811.41%469.37K | -50.42%694.11K | 9.49%2.71M | -174.16%-1.24M | 151.18%2.5M | 119.91%51.5K | 1,939.21%1.4M | 241.55%2.47M | 153.96%1.67M | -27.83%993.88K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 10,799.16%2.76M | 28.19%-236.37K | 63.31%-627.84K | 251.25%1.16M | -2,159.32%-1.43M | 82.77%-25.8K | 55.01%-329.15K | -228.65%-1.71M | -146.17%-766.66K | 98.03%-63.4K |
| Net PPE purchase and sale | 18,551.40%4.76M | -85.90%-236.37K | 140.88%92.46K | 3,095.53%177.64K | 206.89%67.77K | 82.77%-25.8K | -1,691.87%-127.15K | 88.73%-226.18K | 99.57%-5.93K | 89.91%-63.4K |
| Net intangibles purchas and sale | --0 | --0 | 96.60%-50.5K | 317.12%1.65M | ---1.5M | --0 | 72.12%-202K | -140.29%-1.49M | -125.18%-760.73K | --0 |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 |
| Net investment purchase and sale | ---- | ---- | ---669.8K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 10,799.16%2.76M | 28.19%-236.37K | 63.31%-627.84K | 251.25%1.16M | -2,159.32%-1.43M | 82.77%-25.8K | 55.01%-329.15K | -228.65%-1.71M | -146.17%-766.66K | 98.03%-63.4K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -179.47%-2.12M | -21.22%-303.62K | -239.39%-1.57M | -244.10%-302.47K | -31.91%-260.45K | -288.74%-756.85K | -119.14%-250.47K | -10.60%1.13M | -92.53%209.91K | -172.02%-197.45K |
| Net issuance payments of debt | -179.47%-2.12M | -21.22%-303.62K | -79.77%-1.57M | -244.10%-302.47K | -31.91%-260.45K | -288.74%-756.85K | 63.76%-250.47K | 88.42%-873.47K | 211.25%209.91K | -172.02%-197.45K |
| Net common stock issuance | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -65.52%2M | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -179.47%-2.12M | -21.22%-303.62K | -239.39%-1.57M | -244.10%-302.47K | -31.91%-260.45K | -288.74%-756.85K | -119.14%-250.47K | -10.60%1.13M | -92.53%209.91K | -172.02%-197.45K |
| Net cash flow | ||||||||||
| Beginning cash position | -2.68%5.63M | 10.29%5.48M | 61.36%4.97M | 52.05%5.86M | 62.02%5.06M | 55.41%5.79M | 61.36%4.97M | 37.65%3.08M | 150.93%3.85M | 1.11%3.12M |
| Current changes in cash | 252.43%1.11M | -81.21%154.12K | -72.95%511.05K | -134.28%-381.78K | 9.62%803.55K | -21.22%-731.15K | 27.03%820.41K | 124.35%1.89M | -19.03%1.11M | 146.79%733.03K |
| Effect of exchange rate changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| End cash Position | 33.42%6.75M | -2.68%5.63M | 10.29%5.48M | 10.29%5.48M | 52.05%5.86M | 62.02%5.06M | 55.41%5.79M | 61.36%4.97M | 61.36%4.97M | 150.93%3.85M |
| Free cash from | 793.55%229.64K | -57.26%457.74K | 222.22%2.46M | -55.86%399.03K | 3.49%962.92K | 106.29%25.7K | 261.54%1.07M | 117.45%762.99K | 162.23%903.91K | 132.19%930.48K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.